03/03/2026
Cheek filler is often misunderstood as a contouring treatment.
In clinical practice, the primary indication is structural midface volume loss. Ageing involves deep fat pad atrophy, superficial compartment descent and gradual maxillary bone resorption. This reduces anterior projection and alters how soft tissue is supported.
When indicated, hyaluronic acid filler is placed at specific anatomical layers — commonly supraperiosteal over the zygomatic arch or within deep medial cheek fat compartments. The objective is to restore structural support and redistribute tissue tension, not to create exaggerated projection.
This approach does not correct significant skin laxity or replace surgical intervention. It is a volumetric treatment and should be planned according to anatomical deficit, tissue quality and overall facial proportion.
Clinical decisions are based on structure, not trends.
MedicalAesthetics AestheticMedicine StructuralSupport HyaluronicAcid EvidenceBasedAesthetics ClinicalApproach FacialAgeing LondonAesthetics WestHampsteadClinic MedicalInjector